Life sciences enterprises are embracing digital technologies to navigate the growing complexities in drug development, commercialization, and regulatory compliance. As economic pressures and competitive dynamics intensify, organizations are turning to digital services to improve operational resilience and achieve faster time-to-market. Providers are responding with targeted investments in AI / generative AI, data platforms, and industry-specific solutions to meet enterprise demands across the life sciences value chain.

This PEAK Matrix^® report offers a detailed evaluation of 35 providers delivering digital services in the life sciences sector, including biopharmaceutical, medical device, and others. It examines how these providers are enabling transformation through scalable solutions, co-innovation models, and differentiated capabilities. By assessing providers across dimensions such as market adoption, innovation, and delivery footprint, the report helps enterprise buyers identify the right strategic partners for their digital agendas.

Scope

• Industry: life sciences (biopharmaceutical, medical devices, and others)
• Service: digital services
• Geography: global

Contents

In this report, we offer:

• Providers’ evaluations
• The evaluation scope
• Market trends
• Provider landscape analysis
• Key buyer considerations and takeaways

Memberships

Life Sciences Information Technology

Sourcing and Vendor Management